Investors
Information Disclosure
-
POSITIVE PROFIT ALERT2022.03.15
-
VOLUNTARY ANNOUNCEMENT - "LURASIDONE HYDROCHLORIDE TABLETS" OBTAINED DRUG REGISTRATION CERTIFICATE2022.03.14
-
VOLUNTARY ANNOUNCEMENT - “IGURATIMOD” API OBTAINED REGISTRATION CERTIFICATE FROM PMDA2022.03.11
-
VOLUNTARY ANNOUNCEMENT - ENTERING INTO COOPERATIVE DEVELOPMENT AGREEMENT FOR FULLY HUMAN ANTIBODY DRUGS2022.03.11
-
VOLUNTARY ANNOUNCEMENT - "SITAGLIPTIN PHOSPHATE TABLET" OBTAINED DRUG REGISTRATION CERTIFICATES2022.03.10
-
VOLUNTARY ANNOUNCEMENT - "TOFACITINIB CITRATE TABLET" OBTAINED DRUG REGISTRATION CERTIFICATE2022.03.10
-
VOLUNTARY ANNOUNCEMENT - "TDI01" SUSPENSION OBTAINED APPROVAL FOR PNEUMOCONIOSIS CLINICAL TRIAL2022.03.08
-
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 20222022.03.01